Glenmark Pharmaceuticals, based in Mumbai, has developed MINYM, India’s first topical Minocycline 4 percent gel for the treatment of moderate to severe acne.
This is an effective antibacterial gel with anti-inflammatory properties. It also has the lowest MIC90 (minimum Inhibitory Concentration at which it stops/prevents visible growth of 90 percent of bacteria isolates) among available topical antibacterial formulations.
MINYM Gel (Topical Minocycline 4 percent gel) has been developed to address these rising issues in the treatment of acne and is safe to use in patients over the age of nine.
In a study on the prevalence of acne in India conducted by Glenmark in 2020, it was observed that 45 percent of the patients were males and 55 percent were females; and over 72 percent of the patients were in the adolescent group, while 27 percent were in the adult group.
